X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Indoco Remedies Quarterly Results - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Indoco Remedies Quarterly Results   (INDOCO)

Here are the latest quarterly results of Indoco Remedies. For more details, see the Indoco Remedies financial fact sheet and Indoco Remedies share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Indoco Remedies Quarterly Results

No. of Mths
Qtr. Ending
3
Jun-15
3
Sep-15
3
Dec-15
3
Mar-16
3
Jun-16
3
Sep-16
3
Dec-16
3
Mar-17
*
8-Qtr Chart
Click to enlarge
Net Sales Rs m2,2342,5492,5862,6342,5742,8102,7822,769 
Other income Rs m23253101117 
Turnover Rs m2,2362,5522,5882,6402,5772,8202,7932,786 
Expenses Rs m1,8082,0922,1552,2262,1562,3912,3872,413 
Gross profit Rs m426458431408418420395357 
Depreciation Rs m150149152153168167144154 
Interest Rs m2226284724162916 
Profit before tax Rs m257285253215229247234204 
Tax Rs m5459491431265824 
Profit after tax Rs m203226204200198221176179 
Gross profit margin %19.117.916.715.516.214.914.212.9 
Effective tax rate %21.020.719.26.713.510.524.712.0 
Net profit margin %9.18.97.97.67.77.96.36.5 
Diluted EPS Rs 2.2 2.5 2.2 2.2 2.1 2.4 1.9 1.9  
Diluted EPS (TTM) Rs 9.0 9.0 8.9 9.0 9.0 8.9 8.6 8.4  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

More Miscellaneous Company Quarterly Results:   UNICHEM LAB  SUN PHARMA  NATCO PHARMA  AJANTA PHARMA  STRIDES SHASUN LTD  

Compare INDOCO REMEDIES With:   UNICHEM LAB  SUN PHARMA  NATCO PHARMA  AJANTA PHARMA  STRIDES SHASUN LTD  

Compare INDOCO REMEDIES With:   ACTAVIS (US)  MYLAN (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Closes above 100 Points; IT & Realty Stocks Rally(Closing)

Indian share markets gathered some momentum in the afternoon session to finish above the dotted line amid firm global markets.

Views on news

Suven Lifesciences: Profits Decline due to Higher tax outgo in the quarter (Quarterly Results Update - Detailed)

Sep 22, 2017

Muted growth in CRAMS segment continues to impact topline.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

More Views on News

Most Popular

Timeless Stocks on the Electric Car Assembly Line(The 5 Minute Wrapup)

Oct 10, 2017

Are they on their way to create Coca Cola-like wealth?

Why Merger of Public Sector Banks Continues to Be a Bad Idea(Vivek Kaul's Diary)

Oct 10, 2017

There is enough research evidence that suggests that most mergers don't work.

Electric Vehicles: The Final Piece of the Puzzle(Smart Contrarian)

Oct 16, 2017

Just as there would be gainers from an electric vehicles boom, who possibly could be the biggest losers.

Mutual Funds Re-categorised... But What About Stocks?(Daily Profit Hunter)

Oct 11, 2017

The market regulator can solve systemic issues but you must tackle the behavioral biases on your own.

Companies Are Wary of Borrowing(Chart Of The Day)

Oct 17, 2017

How to profit from behavioral biases afflicting the industry.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2018
Get our special report, Multibagger Stocks Guide (2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

INDOCO REMEDIES SHARE PRICE


Oct 23, 2017 (Close)

TRACK INDOCO REMEDIES

  • Track your investment in INDOCO REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON INDOCO REMEDIES

INDOCO REMEDIES 5-YR ANALYSIS

COMPARE INDOCO REMEDIES WITH

MARKET STATS